Nucleic Acid-based Therapeutics Market Overview The nucleic acid-based therapeutics market represents a revolutionary frontier in medicine, focusing on the use of genetic material such as DNA and RNA to treat and prevent diseases. This innovative class of therapeutics includes modalities like gene therapy, antisense oligonucleotides, RNA interference (RNAi), microRNA-based therapies, and mRNA vaccines. These approaches aim to modulate gene expression, correct genetic defects, or induce an immune response at the fundamental molecular level. The market is characterized by intense research and development efforts, driven by the potential to address previously untreatable genetic disorders, cancers, and infectious diseases. The increasing understanding of the human genome and advancements in delivery technologies are crucial for the progress of this field. As more nucleic acid-based therapies receive regulatory approval and demonstrate clinical efficacy, the market is poi...